SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Summit Therapeutics (SMMT)

SMMT RSS Feed
Add SMMT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/26/2016 9:14:41 AM - Followers: 2 - Board type: Free - Posts Today: 0
Summit Therapeutics NASDAQ:SMMT

UK based company that also trades as LSE:SUMM

http://www.summitplc.com/

We are a clinical-stage drug discovery and development company advancing innovative therapies to significantly advance the current standard of treatment for serious unmet medical needs.

Our strategy focuses on two therapy areas: Duchenne Muscular Dystrophy, a fatal genetic muscle wasting disease, and the infectious disease caused by the bacteria C. difficile.

Events and Presentation: http://www.summitplc.com/investors/presentations/

SEC filings: https://www.sec.gov/cgi-bin/browse-edgar?company=Summit+Therapeutics&owner=exclude&action=getcompany
 





All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Rules of the board according to IHUB:
http://www.investorshub.com/boards/complex_terms.asp

 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SMMT
Current Price
Volume:
Bid Ask Day's Range
SureTrader
SMMT News: Summit Receives Rare Pediatric Disease Designation From US FDA for Ezutromid in Treatment of Duchenne Muscular Dystrophy 07:00 AM
SMMT News: Report of Foreign Issuer (6-k) 09/26/2016 04:58:06 PM
SMMT News: Summit Receives Fast Track Designation From US FDA for Ezutromid in the Treatment of Duchenne Muscular Dystrophy 09/26/2016 07:00:00 AM
SMMT News: Summit Launches Online Resource on Utrophin Modulation for the Duchenne Muscular Dystrophy Community 09/12/2016 07:00:00 AM
SMMT News: Report of Foreign Issuer (6-k) 09/08/2016 05:07:07 PM
News News Alert: Summit Receives Rare Pediatric Disease Designation From US FDA for Ezutromid in Treatment of Duchenne Muscular Dystrophy 09/27/2016 07:00:00 AM
PostSubject
#1   Summit Receives Fast Track Designation From US FDA Dr_Thorfin 09/26/16 09:14:41 AM
PostSubject